Pirfenidone (PFD) is a drug that alleviates pulmonary fibrosis by producing an anti-inflammatory effect and modulating the NF-κB, TGF-β, and Wnt signaling pathways [164,165,166]. Here, TGFB1 is linked to pulmonary fibrosis.